While FDA's internal reviewers excel at policy analysis, traditional research and enforcement, the compounding advisory committee exists to inject the kind of frontline clinical and industry perspective that comes only from working outside the agency with real patients
In 2023, the agency reclassified BPC-157 and 18 other manmade peptides as Category 2 Bulk Drug Substances, effectively barring compounding pharmacies from producing them, citing safety concerns and insufficient information on their effects in humans
Toradol Medication used for pain management
After initial repletion, a maintenance dose is given, often 1,000 mcg intramuscularly every month or every 2 to 3 months, to prevent recurrence of deficiency
BPC-157 wird als lyophilisiertes Pulver (Gefriertrocknung) in einer Dosierung von 5 mg pro Vial angeboten
Theres so much to talk about with that